Interestingly, SFRP1 re-expression diminished the canonical WNT/β-catenin signaling activity and we detected a downregulation of the WNT target genes MYC and CCND1, although the HB cell lines carry beta-catenin mutations. The gene discussed is CCND1; the disease is hemoglobin measurement.